440 related articles for article (PubMed ID: 4330088)
21. Interrelation of prostaglandin endoperoxide (prostaglandin G2) and cyclic 3',5'-adenosine monophosphate in human blood platelets.
Salzman EW
Biochim Biophys Acta; 1977 Aug; 499(1):48-60. PubMed ID: 196670
[TBL] [Abstract][Full Text] [Related]
22. The tumor-promoter phorbol ester (12-O-tetradecanoyl-phorbol-13-acetate), a potent aggregating agent for blood platelets.
Zucker MB; Troll W; Belman S
J Cell Biol; 1974 Feb; 60(2):325-36. PubMed ID: 4360292
[TBL] [Abstract][Full Text] [Related]
23. Interaction of prostaglandins E1 and E2 in regulation of cyclic-AMP and aggregation in human platelets: evidence for a common prostaglandin receptor.
McDonald JW; Stuart RK
J Lab Clin Med; 1974 Jul; 84(1):111-21. PubMed ID: 4365532
[TBL] [Abstract][Full Text] [Related]
24. Potentiation of the antiplatelet action of adenosine in whole blood by dipyridamole or dilazep and the cAMP phosphodiesterase inhibitor, RA 233.
Dawicki DD; Agarwal KC; Parks RE
Thromb Res; 1986 Jul; 43(2):161-75. PubMed ID: 3016942
[TBL] [Abstract][Full Text] [Related]
25. Cyclic 3',5'-adenosine monophosphate in human blood platelets. 3. The role of cyclic AMP in platelet aggregation.
Salzman EW; Rubino EB; Sims RV
Ser Haematol; 1970; 3(4):100-13. PubMed ID: 4329913
[No Abstract] [Full Text] [Related]
26. Cyclic 3',5'-adenosine monophosphate in human blood platelets. IV. Regulatory role of cyclic amp in platelet function.
Salzman EW; Kensler PC; Levine L
Ann N Y Acad Sci; 1972 Oct; 201():61-71. PubMed ID: 4346063
[TBL] [Abstract][Full Text] [Related]
27. Potentiating effect of adenosine on other inhibitors of platelet aggregation.
Murakami M; Odake K; Takase M; Yoshino K
Thromb Diath Haemorrh; 1972 Apr; 27(2):252-62. PubMed ID: 5049615
[No Abstract] [Full Text] [Related]
28. Potentiation of antiaggregating activity of adenosine by a phosphodiesterase inhibitor, EG626 (oxagrelate), in human platelets in vitro.
Azuma H; Takashima Y; Ishikawa M; Yamakado T
Jpn J Pharmacol; 1984 Feb; 34(2):159-70. PubMed ID: 6205194
[TBL] [Abstract][Full Text] [Related]
29. Effects of protopine on blood platelet aggregation. II. Effect on metabolic system of adenosine 3',5'-cyclic monophosphate in platelets.
Shiomoto H; Matsuda H; Kubo M
Chem Pharm Bull (Tokyo); 1990 Aug; 38(8):2320-2. PubMed ID: 2177684
[TBL] [Abstract][Full Text] [Related]
30. Effects of the lonophore A23187 on blood platelets I. Influence on aggregation and secretion.
White JG; Rao GH; Gerrard JM
Am J Pathol; 1974 Nov; 77(2):135-49. PubMed ID: 4374890
[TBL] [Abstract][Full Text] [Related]
31. Neuroblastoma clones: prostaglandin versus dibutyryl cyclic AMP, 8-benzylthio-cyclic AMP, phosphodiesterase inhibitors and x-rays.
Prasad KN
Proc Soc Exp Biol Med; 1972 May; 140(1):126-9. PubMed ID: 4338181
[No Abstract] [Full Text] [Related]
32. Factors influencing the response of human blood platelets to analogues of ADP which may act as partial agonists at the ADP receptor.
Egan CM; Fisher AP; Scrutton MC
Eur J Biochem; 1979 Mar; 95(1):127-37. PubMed ID: 110586
[TBL] [Abstract][Full Text] [Related]
33. Binding of adenosine diphosphate to intact human platelets.
Born GV; Feinberg H
J Physiol; 1975 Oct; 251(3):803-16. PubMed ID: 1185683
[TBL] [Abstract][Full Text] [Related]
34. Cyclic AMP and platelet prostaglandin synthesis.
Gerrard JM; Peller JD; Krick TP; White JG
Prostaglandins; 1977 Jul; 14(1):39-50. PubMed ID: 197570
[TBL] [Abstract][Full Text] [Related]
35. Effect of RA233 on platelet function in vitro.
Hassanein AA; Turpie AG; McNicol GP; Douglas AS
Br Med J; 1970 Apr; 2(5701):83-6. PubMed ID: 5420238
[TBL] [Abstract][Full Text] [Related]
36. Cyclic AMP and platelet aggregation.
Hugues J
Acta Univ Carol Med Monogr; 1972; 53():179-84. PubMed ID: 4364682
[No Abstract] [Full Text] [Related]
37. Substances that increase the cyclic AMP content prevent platelet aggregation and the concurrent release of pharmacologically active substances evoked by arachidonic acid.
Vargaftig BB; Chignard M
Agents Actions; 1975 May; 5(2):137-44. PubMed ID: 51579
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of cyclic-3',5'-nucleotide-phosphodiesterase as a possible mode of action of papaverine and similarly acting drugs.
Kukovetz WR; Pöch G
Naunyn Schmiedebergs Arch Pharmakol; 1970; 267(2):189-94. PubMed ID: 4320455
[No Abstract] [Full Text] [Related]
39. Cilostazol and dipyridamole synergistically inhibit human platelet aggregation.
Liu Y; Cone J; Le SN; Fong M; Tao L; Shoaf SE; Bricmont P; Czerwiec FS; Kambayashi J; Yoshitake M; Sun B
J Cardiovasc Pharmacol; 2004 Aug; 44(2):266-73. PubMed ID: 15243309
[TBL] [Abstract][Full Text] [Related]
40. Effects of adenosine on levels of adenosine cyclic 3',5'-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation.
Haslam RJ; Rosson GM
Mol Pharmacol; 1975 Sep; 11(5):528-44. PubMed ID: 170501
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
